| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS | REGISTER |
|
|
|
|
|||||||||||||
|
|
|||||||||||||||
ORIGINAL ARTICLE |
1 Department of Internal Medicine, University Hospital, Anichstrasse 35, A-6020 Innsbruck, Austria
2 Institute of Pathology, University of Basel, CH 4003 Basel, Switzerland
3 Department of Surgery, University Hospital, Innsbruck
4 Department of Surgery, Natters State Hospital, Austria
Correspondence to:
Dr W Hilbe
Department of Internal Medicine, Innsbruck University Hospital, Anichstrasse 35, A-6020 Innsbruck, Austria; wolfgang.hilbe{at}uibk.ac.at
Aims: Recent results generated in a mouse model suggest that tumour angiogenesis/vasculogenesis can be initiated and maintained by bone marrow derived endothelial progenitor cells. This present study investigated the distribution and frequency of CD133 positive endothelial progenitor cells in patients with non-small cell lung cancer (NSCLC) (tumour tissue and tumour free lung regions) and healthy controls using fresh frozen specimens. The novel marker CD133 identifies human haemopoetic precursor cells, in addition to human endothelial progenitor cells.
Methods: Seventy nine lung cancer specimens and 66 adjacent histologically tumour free tissues of the same patient cohort were analysed; 11 postmortem specimens from control patients who did not suffer from malignant disease served as controls. Cryostat sections were stained for CD133, CD31, vascular endothelial growth factor receptor 2 (VEGFR-2; KDR), p53, and the proliferation marker Ki-67, and the correlations were analysed.
Results: Forty three of 63 evaluable tumour specimens had increased numbers of CD133 positive cells and in some cases capillary forming CD133 positive structures were detectable. In addition, 30 of 63 specimens had raised expression of KDR and 29 of 63 had increased MVD. Increased CD133 expression marginally correlated with raised KDR expression but not with p53 and Ki-67.
Conclusion: A significant increase in CD133 positive cells was documented in patients with NSCLC, suggesting an involvement of endothelial progenitor cells in tumour vasculogenesis and tumour growth in these patients.
Abbreviations: EC, endothelial cell; EPC, endothelial progenitor cell; MVD, microvessel density; NSCLC, non-small cell lung cancer; VEGF, vascular endothelial growth factor; VEGFR, vascular endothelial growth factor receptor
Keywords: lung cancer; immunohistochemistry; CD133; angiogenesis; endothelial progenitor cell
This article has been cited by other articles:
|
|
 |
|
  A. S. Arbab, B. Janic, R. A. Knight, S. A. Anderson, E. Pawelczyk, A. M. Rad, E. J. Read, S. D. Pandit, and J. A. Frank Detection of migration of locally implanted AC133+ stem cells by cellular magnetic resonance imaging with histological findings FASEB J, September 1, 2008; 22(9): 3234 - 3246. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. J. Weiss, J. K. Kolls, L. A. Ortiz, A. Panoskaltsis-Mortari, and D. J. Prockop Stem Cells and Cell Therapies in Lung Biology and Lung Diseases Proceedings of the ATS, July 15, 2008; 5(5): 637 - 667. [Full Text] [PDF]
|
|
|
|
 |
|
 A. Zampetaki, J. P. Kirton, and Q. Xu Vascular repair by endothelial progenitor cells Cardiovasc Res, June 1, 2008; 78(3): 413 - 421. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. Yu, X. Sun, Y. Qiu, J. Zhou, Y. Wu, L. Zhuang, J. Chen, and Y. Ding Identification and Clinical Significance of Mobilized Endothelial Progenitor Cells in Tumor Vasculogenesis of Hepatocellular Carcinoma Clin. Cancer Res., July 1, 2007; 13(13): 3814 - 3824. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. Igreja, M. Courinha, A. S. Cachaco, T. Pereira, J. Cabecadas, M. G. da Silva, and S. Dias Characterization and clinical relevance of circulating and biopsy-derived endothelial progenitor cells in lymphoma patients Haematologica, April 1, 2007; 92(4): 469 - 477. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Bruno, B. Bussolati, C. Grange, F. Collino, M. E. Graziano, U. Ferrando, and G. Camussi CD133+ Renal Progenitor Cells Contribute to Tumor Angiogenesis Am. J. Pathol., December 1, 2006; 169(6): 2223 - 2235. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 B. Dome, J. Timar, J. Dobos, L. Meszaros, E. Raso, S. Paku, I. Kenessey, G. Ostoros, M. Magyar, A. Ladanyi, et al. Identification and clinical significance of circulating endothelial progenitor cells in human non-small cell lung cancer. Cancer Res., July 15, 2006; 66(14): 7341 - 7347. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
N. Ma, Y. Ladilov, J. M. Moebius, L. Ong, C. Piechaczek, A. David, A. Kaminski, Y.-H. Choi, W. Li, D. Egger, et al. Intramyocardial delivery of human CD133+ cells in a SCID mouse cryoinjury model: Bone marrow vs. cord blood-derived cells Cardiovasc Res, July 1, 2006; 71(1): 158 - 169. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. J. Weiss, M. A. Berberich, Z. Borok, D. B. Gail, J. K. Kolls, C. Penland, and D. J. Prockop Adult Stem Cells, Lung Biology, and Lung Disease Proceedings of the ATS, May 1, 2006; 3(3): 193 - 207. [Full Text] [PDF]
|
|
|
|
 |
|
 C. M. Sheridan, D. Rice, P. S. Hiscott, D. Wong, and D. L. Kent The Presence of AC133-Positive Cells Suggests a Possible Role of Endothelial Progenitor Cells in the Formation of Choroidal Neovascularization. Invest. Ophthalmol. Vis. Sci., April 1, 2006; 47(4): 1642 - 1645. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Rafii and D. Lyden Contribution of Hematopoietic and Vascular Progenitor Cells to the Neoangiogenic Niche Am. Assoc. Cancer Res. Educ. Book, April 1, 2006; 2006(1): 181 - 185. [Full Text] [PDF]
|
|
|
|
 |
|
 G. M. Rigolin, C. Fraulini, M. Ciccone, E. Mauro, A. M. Bugli, C. De Angeli, M. Negrini, A. Cuneo, and G. Castoldi Neoplastic circulating endothelial cells in multiple myeloma with 13q14 deletion Blood, March 15, 2006; 107(6): 2531 - 2535. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. S. Arbab, V. Frenkel, S. D. Pandit, S. A. Anderson, G. T. Yocum, M. Bur, H. M. Khuu, E. J. Read, and J. A. Frank Magnetic Resonance Imaging and Confocal Microscopy Studies of Magnetically Labeled Endothelial Progenitor Cells Trafficking to Sites of Tumor Angiogenesis Stem Cells, March 1, 2006; 24(3): 671 - 678. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. Jaatinen, H. Hemmoranta, S. Hautaniemi, J. Niemi, D. Nicorici, J. Laine, O. Yli-Harja, and J. Partanen Global Gene Expression Profile of Human Cord Blood-Derived CD133+ Cells Stem Cells, March 1, 2006; 24(3): 631 - 641. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. A. Hess, L. Wirthlin, T. P. Craft, P. E. Herrbrich, S. A. Hohm, R. Lahey, W. C. Eades, M. H. Creer, and J. A. Nolta Selection based on CD133 and high aldehyde dehydrogenase activity isolates long-term reconstituting human hematopoietic stem cells Blood, March 1, 2006; 107(5): 2162 - 2169. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 H. Spring, T. Schuler, B. Arnold, G. J. Hammerling, and R. Ganss Chemokines direct endothelial progenitors into tumor neovessels PNAS, December 13, 2005; 102(50): 18111 - 18116. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 B Dome, J Timar, G Ostoros, and S Paku Endothelial progenitor cells in non-small cell lung cancer J. Clin. Pathol., April 1, 2005; 58(4): 447 - 447. [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS | REGISTER |
| Journal of Clinical Pathology | Molecular Pathology |
